134 related articles for article (PubMed ID: 27562925)
21. Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: Biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor.
Zhao Y; Sotolongo G; Deak K; Wang E
Hematol Oncol; 2021 Apr; 39(2):254-257. PubMed ID: 33137210
[No Abstract] [Full Text] [Related]
22. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
Jain P; Verstovsek S; Wang W; Loghavi S; Torres HA; Estrov Z; Patel KP; Pemmaraju N
Leuk Lymphoma; 2016 Aug; 57(8):1969-73. PubMed ID: 26700872
[No Abstract] [Full Text] [Related]
23. No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.
Poletto V; Villani L; Catarsi P; Campanelli R; Massa M; Vannucchi AM; Rosti V; Barosi G
Haematologica; 2013 Aug; 98(8):e83-4. PubMed ID: 23716550
[No Abstract] [Full Text] [Related]
24. Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.
Passamonti F; Rumi E; Elena C; Arcaini L; Merli M; Pascutto C; Cazzola M; Lazzarino M
Br J Haematol; 2010 Sep; 150(6):719-21. PubMed ID: 20560961
[No Abstract] [Full Text] [Related]
25. Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis.
Berneman ZN; Anguille S; Van Marck V; Schroyens WA; Van Tendeloo VF
Br J Haematol; 2010 Apr; 149(1):152-5. PubMed ID: 19995392
[No Abstract] [Full Text] [Related]
26. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
[TBL] [Abstract][Full Text] [Related]
27. Double transformation of a hematopoietic malignancy and severe associated thrombopathy. Case presentation and review of the literature.
Cişleanu D; Onisâi M; Vlădăreanu AM; Găman M; Neagul AM; Bumbea H; Iova A; Baluţa C; Cazaceanu O; Begu M; Ilea A
Rom J Intern Med; 2011; 49(2):137-44. PubMed ID: 22303605
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
Passamonti F; Rumi E; Pietra D; Elena C; Boveri E; Arcaini L; Roncoroni E; Astori C; Merli M; Boggi S; Pascutto C; Lazzarino M; Cazzola M
Leukemia; 2010 Sep; 24(9):1574-9. PubMed ID: 20631743
[TBL] [Abstract][Full Text] [Related]
29. Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.
Park SH; Chi HS; Shim H; Jang S; Park CJ
Int J Lab Hematol; 2013 Feb; 35(1):e1-3. PubMed ID: 22978565
[No Abstract] [Full Text] [Related]
30. [The long-term persistence of cell clone 47,XX,+I(1Q) in a female patient with multiyear complete clinico-hematological remission of acute myeloid leukemia].
Kobzev IuN; Udovichenko AI; Aseeva EA; Domracheva EV; Zakharova AV; Diachenko LV; Kuchma IuM
Ter Arkh; 1997; 69(7):59-61. PubMed ID: 9424763
[No Abstract] [Full Text] [Related]
31. Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ; Rosillo C; Camoriano JK
Am J Hematol; 2007 May; 82(5):400-2. PubMed ID: 17133423
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy of acute myeloid leukemia of 35- to 60-year-old patients.
Fleischer J; Reinhardt U; Wolf H; Helbig W; Anger G; Grau I; Schott G; Konrad H; Klinkenstein C; Steglich J
Haematol Blood Transfus; 1990; 33():392-4. PubMed ID: 2323648
[No Abstract] [Full Text] [Related]
33. [Factors influencing leukemic transformation in myelodysplastic syndrome].
Borbényi Z; Varga G; Bérczi M; Gurzó M
Orv Hetil; 1990 Jun; 131(23):1231-6, 1239-40. PubMed ID: 2199892
[TBL] [Abstract][Full Text] [Related]
34. Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.
Fiorini A; Reddiconto G; Farina G; Marietti S; Palladino M; Chiusolo P; Leone G; Sica S
Leukemia; 2006 Dec; 20(12):2198-9. PubMed ID: 17039230
[No Abstract] [Full Text] [Related]
35. Long-term Remission of Acute Myeloid Leukemia Developed From Systemic Mastocytosis by Conventional Chemotherapy.
Yamada A; Kinoshita M; Sawa D; Saito Y; Kamimura S; Miyachi H; Moritake H
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e402-e404. PubMed ID: 30044348
[TBL] [Abstract][Full Text] [Related]
36. Cyclic severe elevated procalcitonin serum levels in a patient with post polycythemic myelofibrosis carrying a V617F-JAK2 mutation.
Stölzel F; Babatz J; Thiede C; Siegert G; Illmer T; Ehninger G; Schaich M
Ann Hematol; 2008 Dec; 87(12):1021-2. PubMed ID: 18548249
[No Abstract] [Full Text] [Related]
37. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.
Malak S; Labopin M; Saint-Martin C; Bellanne-Chantelot C; Najman A;
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):170-6. PubMed ID: 22818858
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.
Kandarpa M; Wu YM; Robinson D; Burke PW; Chinnaiyan AM; Talpaz M
Am J Hematol; 2017 Jun; 92(6):555-561. PubMed ID: 28335073
[TBL] [Abstract][Full Text] [Related]
39. Diffuse osteosclerosis-associated acute myeloid leukemia.
Ward DE; Fondaw MB; Shroff SK; Reddy VS; Khaled YA
J Clin Oncol; 2012 Jan; 30(1):e3-4. PubMed ID: 22124108
[No Abstract] [Full Text] [Related]
40. Acute promyelocytic leukemia with secondary myelofibrosis -- case report and review of the literature.
Dutta P; Hasan S; Bhattacharyya J; Kumar R; Mahapatra M; Saxena R; Tyagi S; Sazawal S; Pati HP
Am J Hematol; 2006 Jun; 81(6):476-7. PubMed ID: 16680747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
